NVS - Novartis - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.07T

Cash

12.19B

Avg Qtr Burn

N/A

Short % of Float

0.00%

Insider Ownership

0.01%

Institutional Own.

8.25%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ABL001/SCEMBLIX Details Chronic myelomonocytic leukemia, Blood cancer, Cancer, Leukemia	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.